PRKD1 and Huntington disease: The decreased neuronal levels of PKD in the striatum of HD patients and R6/1 mice, coupled with the deleterious effects of PKD inhibition in cultured striatal neurons under excitotoxic conditions, suggested that increasing PKD activity might confer neuroprotection to these neurons.